TME |
Tumor microenvironment |
TAMC |
Tumor-associated myeloid cell |
M/PMN/eMDSC |
Monocytic/polymorphonuclear/early-stage–myeloid-derived suppressor cell |
UPR |
Unfolded protein response |
CHOP |
C/EBP homologous protein |
XBP1 |
X-box binding protein 1 |
IRE1α |
Inositol-requiring enzyme |
MMP |
Matrix metalloproteinase |
VEGFR2 |
Vascular endothelial growth factor receptor2 |
CD31 |
Platelet endothelial cell adhesion molecule1 |
TIE2 |
Tyrosine kinase with immunoglobulin and EGF-like domains |
VEGF |
Vascular endothelial growth factor |
FGF |
Fibroblast growth factor |
ANG2 |
Angiopoietin 2 |
CXCL12 |
C-X-C motif chemokine 12 |
SDF-1α |
Stromal derived factor-1α |
EC |
Endothelial cell |
TEM |
TIE2-expressing macrophage |
EPC |
Endothelial progenitor cell |
AAT |
Antiangiogenic therapy |